Pain
The conventional wisdom that neurosurgical patients experience minimal postoperative pain and require little analgesia has been challenged. In one study results confirm that the average craniotomy patient has less postoperative pain than patients who undergo other surgical procedures, although patients who undergo frontal craniotomy may require more aggressive pain management.
Nausea and vomiting
Nausea and vomiting are frequent and protracted after supratentorial and infratentorial craniotomy. A prospective, randomized, placebo-controlled, double-blind study was designed to evaluate the efficacy of Ondansetron, a 5-HT3 antagonist, in preventing postoperative nausea and vomiting (PONV) after elective craniotomy in adult patients. Administration of single-dose Ondansetron (8 mg intravenously) at wound closure was partially effective in reducing acute nausea and vomiting but had little delayed benefit. Ondansetron is very effective for nausea and vomiting prophylaxis after fentanyl/isoflurane/relaxant anesthesia and infratentorial craniotomy. Reduced vomiting frequency was seen with Ondansetron at 4, 8, 12, and 24 hours (P < .05).
Infection
The incidence of postoperative infection following craniotomy is of the order of 10%. An 8.9%-postcraniotomy meningitis incidence was found in one study. Postcraniotomy meningitis resulted in a high mortality rate and a longer hospital stay, with repeat operation identified among the risk factors. Gram-negative bacilli were the most common etiologic agents isolated. Although several risk factors were identified by univariate analysis, including postoperative external ventricular shunt (OR = 2.92, CI 95% = 1.245-6.865, P =.014), remote site infection (OR = 2.85, CI 95% = 0.995-8.173, P =.051), and repeat operation (OR = 5.02, CI 95% = 1.569-16.066, P =.007), only repeat operation remained in the multivariate analysis model (OR = 3.68, CI 95% = 1.158-11.700, P =.027).